Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
08/2013
08/13/2013US8507723 Polycationic compounds and uses thereof
08/13/2013CA2629348C Glucagon receptor antagonists, preparation and therapeutic uses
08/08/2013WO2013116174A1 Mglu 2/3 agonists
08/08/2013WO2013077775A3 Method for producing high-purity crystalline carbamide
08/08/2013WO2013072933A3 Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide
08/07/2013EP2623495A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
08/07/2013EP2621894A1 Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide
08/07/2013EP2621893A1 Process for the preparation of amino acid derivatives
08/07/2013CN103232363A Method for continuously preparing poly(amido-amine)
08/07/2013CN103232362A Process for extracting L-glutamine
08/07/2013CN103232361A N-phenylacetyl-L-glutamine
08/07/2013CN103232359A Environmental-friendly nitrile hydrolysis method
08/07/2013CN102358721B More stable aceglutamide compound and medicinal composition thereof
08/06/2013US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/06/2013US8501813 γ-secretase inhibitor
08/06/2013US8501716 C7-fluoro substituted tetracycline compounds
08/06/2013CA2648121C Preparation of chiral amides and amines
08/01/2013WO2013111798A1 Serine racemase inhibitor
08/01/2013US20130196953 Genes for biosynthesis of tetracycline compounds and uses thereof
08/01/2013US20130195756 99mTc IMAGING AGENTS AND METHODS OF USE
07/2013
07/31/2013CN103228665A Method for buffering chemical or biological composition
07/31/2013CN103228612A Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
07/31/2013CN103224474A Synthesis of tetracyclines and analogues thereof
07/31/2013CN101973956B Methods for synthesizing isatoic anhydride and N-isopropyl-2-aminobenzamide
07/31/2013CN101851172B Carbon nano tube/organic gel compound and preparation method thereof
07/31/2013CN101460462B Spirocyclic nitriles as protease inhibitors
07/30/2013US8497305 Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof
07/30/2013CA2479764C Hemiasterlin derivatives and uses thereof
07/25/2013WO2013107405A1 Therapeutically active compounds and their methods of use
07/25/2013WO2013107291A1 Therapeutically active compounds and their methods of use
07/25/2013US20130190533 Process for the preparation of amino acid derivatives
07/25/2013US20130190475 Drug-ligand conjugates, synthesis thereof, and intermediates thereto
07/25/2013US20130190407 Calcium receptor-active molecules
07/24/2013EP2616431A1 Novel cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof
07/24/2013CN103214409A Synthesis of tetracyclines and analogues thereof
07/24/2013CN103214391A Chiral compound
07/24/2013CN101600682B Process for making 3-substituted 2-amino-5-halobenzamides
07/24/2013CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof
07/24/2013CN101296898B Histamine-3 receptor antagonists
07/23/2013US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
07/23/2013US8492365 7-substituted tetracycline compounds
07/23/2013CA2577321C Alkylaminoacetamide lubricant additives
07/23/2013CA2566090C Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
07/18/2013US20130184347 Acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
07/18/2013US20130184222 Therapeutically active compositions and their methods of use
07/18/2013US20130183704 Labeling Agent and Methods for Simultaneous Sequencing and Quantification of Multiple Peptides and Proteins Using the Same
07/17/2013CN103204811A Process For Production Of Anthranilamide Compound
07/17/2013CN102363600B Iomeprol preparation method
07/17/2013CN102320990B Method for recovering oxytetracycline from oxytetracycline hydrochloride waste liquid
07/17/2013CN101962338B Crystallization of iodixanol using ultrasound
07/16/2013US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
07/16/2013US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
07/16/2013US8486921 Synthesis of tetracyclines and analogues thereof
07/11/2013WO2013072936A3 A novel process for the preparation of (r)-n-benzyl-2 acetamido-3-methoxypropionamide
07/11/2013US20130178457 Cannabinoid receptor modulators
07/10/2013CN1956946B Modulators of cannabinoid receptors
07/10/2013CN103193671A Method for preparing L-2-aminobutanamide hydrochloride
07/10/2013CN102491918B Alanyl glutamine compound and preparation method thereof
07/09/2013US8481598 Stable dosage forms of levomilnacipran
07/09/2013US8481513 3, 10, and 12a substituted tetracycline compounds
07/09/2013CA2722087C 4-dimethylaminobutyric acid derivatives
07/03/2013CN103183630A Substituted 4-aminocyclohexane derivatives
07/03/2013CN103183625A Anti-HIV compound and preparation method and application thereof
07/02/2013CA2576839C N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/2013
06/27/2013WO2013096771A1 Non-systemic tgr5 agonists
06/27/2013WO2013095169A1 Crystalline minocycline thermo-resistant obtained by recrystallization with carbon dioxide
06/27/2013US20130165443 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
06/27/2013US20130165381 Lipids, lipid complexes and use thereof
06/26/2013CN103172533A New crystal form of Aliskiren hemifumarate, and preparation method and use thereof
06/26/2013CN103172531A Diphenylamine-system compound, polyamide acid composition and polyimide composition thus manufactured and liquid crystal matching agent
06/26/2013CN103172482A Method for preparing first-grade amide from aldoxime or formaldehyde and hydroxylamine
06/25/2013US8470804 11a, 12-derivatives of tetracycline compounds
06/25/2013CA2725425C Homocysteine synthase inhibitor
06/20/2013WO2013007725A3 Aliskiren hemifumarate, crystal form and amorphous solid
06/19/2013CN103159643A Technology for whole membrane extraction of L-glutamine fermentation broth
06/19/2013CN102086165B Application of Pd catalyst in hydrogenation process for producing doxycycline
06/19/2013CN101967108B Methacycline derivative
06/18/2013US8466318 Method of preparing chiral cyclic β-aminocarboxamides
06/18/2013US8466132 Substituted tetracycline compounds
06/13/2013WO2013086373A1 Lipids for the delivery of active agents
06/13/2013WO2013084150A1 Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
06/13/2013WO2013030654A8 Processes for the preparation of (r)-2-acetamido-n-benzyl-3-methoxypropionamide and intermediates thereof
06/13/2013US20130150442 Oligo-benzamide compounds and their use in treating cancers
06/12/2013CN103145581A Aromatic diamine compound containing imide structure as well as preparation method and application thereof
06/12/2013CN102150571B Production method for biological source theanine raw material
06/06/2013WO2013078577A1 Alanyl glutamine compound and preparation method thereof
06/06/2013WO2013078554A1 Compositions of tigecycline and uses thereof
06/05/2013EP2599785A1 Novel methods for the synthesis and purification of oligomers
06/05/2013EP2598476A1 Process for preparation of lacosamide and some n-benzyl-propanamide intermediate derivatives
06/05/2013CN103130696A Anthranilamide compound as well as preparation method and application thereof
06/05/2013CN103130677A Preparation method of aliskiren
06/04/2013US8455550 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
05/2013
05/30/2013WO2013077775A2 Method for producing high-purity crystalline carbamide
05/30/2013WO2012170952A4 Compounds for targeting drug delivery and enhancing sirna activity
05/30/2013CA2856276A1 Method for producing high-purity crystalline carbamide
05/29/2013CN103124721A Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide
05/29/2013CN103122004A Naphthoquinone compound with antitumor activity
05/29/2013CN103122003A Naphthoquinone compound with antitumor activity
05/29/2013CN103122002A Naphthoquinone compound with antitumor activity
05/29/2013CN103121995A 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 162